Clinical trial Recruiting at 1 site Interventional Ages 18 Months to 36 Months

Understanding early development in autism and the effects of ESDM intervention

Official title: Early Neurodivergent Developmental Trajectories in Toddlers and Young Children on the Autism Spectrum and Effectiveness of the Early Start Denver Model in Community Settings

Run by Istituto per la Ricerca e l'Innovazione Biomedica · NCT06494605 · Data updated 2026-11-12

This study is testing how the Early Start Denver Model (ESDM) can help young children with autism develop better and whether different types of support make a difference in their learning.

More Autism Spectrum Disorder trials

Quick facts

Study typeInterventional
Ages18 Months to 36 Months
SexAll
Enrollment33 (estimated)
SponsorIstituto per la Ricerca e l'Innovazione Biomedica
Academic / other
Locations1 site (Messina, ME)
StatusRecruiting
StartedNovember 1, 2021
Main results expectedSeptember 30, 2024
Study endsMay 31, 2025
Registry record updatedMay 1, 2025
Trial IDNCT06494605 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are young children diagnosed with Autism Spectrum Disorder who meet specific developmental criteria and have Italian-speaking parents.

Probably not a fit

Patients with serious medical conditions, significant sensory impairments, or those whose parents do not speak Italian may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the early developmental trajectories of children with Autism Spectrum Disorder (ASD) and evaluates the impact of the Early Start Denver Model (ESDM) intervention. It aims to assess how different characteristics and intensities of support influence individual learning outcomes in young children on the autism spectrum. The study will involve caregiver participation and the use of video recordings to analyze treatment effectiveness. By examining these factors, the research seeks to inform better delivery systems and support for families in various community settings.

Why it matters

Potential benefit: If successful, this study could enhance early intervention strategies for children with autism, leading to improved developmental outcomes.

How similar studies have gone: Previous studies have shown success with similar interventions, particularly the Early Start Denver Model, indicating a promising approach to early autism support.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* unimpaired hand use
* parent agreement to have a caregiver present during all home sessions
* attendance at all intake sessions
* permission to videotape evaluations and ESDM treatment
* Italian as one primary language of the parent
* unimpaired hearing and vision
* developmental quotient of 35 or higher on the Griffith Scale
* meets all of these autism spectrum disorder diagnostic criteria through the Autism Diagnostic Observation Schedule (ADOS; cutoff score of 12 if child produces no words or 10 if child produces some words)

Exclusion Criteria:

* serious parental substance abuse
* parental self-report of bipolar disorder or psychosis
* known genetic syndromes
* serious medical conditions (e.g., encephalitis, concussion, seizure disorder)
* significant sensory impairment
* birth weight \<1600 grams and/or gestational age \< 34 weeks
* history of intraventricular hemorrhage
* known exposure to neurotoxins (including alcohol, drugs)
* non-Italian-speaking parents

Where it's running

  • Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR),
    Messina, Me, Italy
    Recruiting

Study contacts

  • Principal investigator: Liliana Ruta — National Research Council of Italy, Institute for Biomedical Research and Innovation (CNR-IRIB)
  • Study coordinator: Liliana Ruta
  • Email: liliana.ruta@irib.cnr.it
  • Phone: 3387638295

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.